| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemangioma, Cavernous, Central Nervous System | 51 | 2024 | 223 | 9.510 |
Why?
|
| Hemorrhage | 24 | 2023 | 268 | 2.130 |
Why?
|
| rho-Associated Kinases | 11 | 2019 | 159 | 1.950 |
Why?
|
| Brain Neoplasms | 11 | 2022 | 763 | 1.750 |
Why?
|
| Hemangioma, Cavernous | 8 | 2021 | 69 | 1.470 |
Why?
|
| Apoptosis Regulatory Proteins | 13 | 2021 | 199 | 1.410 |
Why?
|
| Intracranial Arteriovenous Malformations | 8 | 2011 | 104 | 1.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2019 | 379 | 1.070 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 6 | 2020 | 36 | 1.050 |
Why?
|
| Central Nervous System Neoplasms | 5 | 2019 | 81 | 1.040 |
Why?
|
| Lung | 19 | 2023 | 1170 | 0.960 |
Why?
|
| NF-kappa B | 14 | 2003 | 445 | 0.940 |
Why?
|
| Disease Models, Animal | 15 | 2021 | 2232 | 0.940 |
Why?
|
| Magnetic Resonance Imaging | 19 | 2023 | 3362 | 0.930 |
Why?
|
| Proto-Oncogene Proteins | 14 | 2021 | 645 | 0.930 |
Why?
|
| Intracranial Hemorrhages | 3 | 2021 | 120 | 0.850 |
Why?
|
| Endothelial Cells | 15 | 2024 | 429 | 0.780 |
Why?
|
| KRIT1 Protein | 14 | 2022 | 62 | 0.750 |
Why?
|
| Mice | 43 | 2023 | 11356 | 0.740 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 5 | 2001 | 66 | 0.730 |
Why?
|
| Simvastatin | 2 | 2019 | 106 | 0.720 |
Why?
|
| Endotoxemia | 6 | 2001 | 18 | 0.680 |
Why?
|
| Enzyme Inhibitors | 3 | 2019 | 639 | 0.670 |
Why?
|
| Cerebral Hemorrhage | 7 | 2023 | 325 | 0.640 |
Why?
|
| Biomarkers | 15 | 2023 | 1718 | 0.640 |
Why?
|
| Membrane Proteins | 6 | 2021 | 1196 | 0.600 |
Why?
|
| Capillary Permeability | 6 | 2021 | 130 | 0.590 |
Why?
|
| Animals | 51 | 2023 | 26589 | 0.570 |
Why?
|
| Mutation | 12 | 2021 | 3968 | 0.540 |
Why?
|
| Cytokines | 7 | 2017 | 778 | 0.470 |
Why?
|
| Microtubule-Associated Proteins | 9 | 2022 | 176 | 0.470 |
Why?
|
| Propranolol | 3 | 2022 | 45 | 0.450 |
Why?
|
| Neutrophil Activation | 4 | 2002 | 11 | 0.440 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2023 | 56 | 0.430 |
Why?
|
| Male | 53 | 2021 | 40973 | 0.420 |
Why?
|
| Humans | 59 | 2024 | 86653 | 0.390 |
Why?
|
| Mice, Inbred BALB C | 16 | 2002 | 1047 | 0.390 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2019 | 589 | 0.380 |
Why?
|
| Brain | 10 | 2020 | 2216 | 0.380 |
Why?
|
| Transcriptome | 5 | 2024 | 580 | 0.370 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2024 | 407 | 0.360 |
Why?
|
| Carrier Proteins | 6 | 2019 | 673 | 0.340 |
Why?
|
| Neutrophils | 6 | 2002 | 307 | 0.330 |
Why?
|
| Resuscitation | 5 | 1995 | 100 | 0.330 |
Why?
|
| Iron | 4 | 2018 | 164 | 0.320 |
Why?
|
| Adult | 22 | 2023 | 25649 | 0.320 |
Why?
|
| Central Nervous System Vascular Malformations | 2 | 2023 | 32 | 0.310 |
Why?
|
| X-Ray Microtomography | 2 | 2019 | 80 | 0.300 |
Why?
|
| Mice, Transgenic | 8 | 2019 | 1540 | 0.300 |
Why?
|
| Lipopolysaccharides | 6 | 2020 | 286 | 0.300 |
Why?
|
| Female | 34 | 2021 | 44537 | 0.290 |
Why?
|
| Mice, Knockout | 8 | 2021 | 1924 | 0.290 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 2 | 2023 | 15 | 0.270 |
Why?
|
| Kruppel-Like Transcription Factors | 4 | 2021 | 93 | 0.270 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 262 | 0.260 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2019 | 378 | 0.260 |
Why?
|
| Sirolimus | 2 | 2023 | 169 | 0.260 |
Why?
|
| Macrophages, Alveolar | 5 | 2000 | 55 | 0.260 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2019 | 1204 | 0.250 |
Why?
|
| RNA, Messenger | 13 | 2021 | 1981 | 0.240 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2020 | 455 | 0.240 |
Why?
|
| B-Lymphocytes | 5 | 2018 | 724 | 0.240 |
Why?
|
| Astrocytes | 2 | 2021 | 139 | 0.240 |
Why?
|
| Young Adult | 10 | 2021 | 5977 | 0.230 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 3 | 2022 | 63 | 0.230 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2003 | 683 | 0.230 |
Why?
|
| Inflammation Mediators | 3 | 2021 | 155 | 0.230 |
Why?
|
| Disease Progression | 4 | 2021 | 1531 | 0.220 |
Why?
|
| Child, Preschool | 7 | 2020 | 3613 | 0.220 |
Why?
|
| Adolescent | 11 | 2020 | 8982 | 0.220 |
Why?
|
| Prospective Studies | 8 | 2023 | 4213 | 0.220 |
Why?
|
| Arteriovenous Malformations | 1 | 2023 | 41 | 0.220 |
Why?
|
| Middle Aged | 20 | 2021 | 25028 | 0.220 |
Why?
|
| Plasma Cells | 3 | 2020 | 80 | 0.220 |
Why?
|
| Gene Expression | 4 | 2003 | 1284 | 0.220 |
Why?
|
| Circulating MicroRNA | 1 | 2022 | 12 | 0.220 |
Why?
|
| Catecholamines | 2 | 1999 | 88 | 0.200 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2021 | 9 | 0.200 |
Why?
|
| Child | 8 | 2020 | 6928 | 0.190 |
Why?
|
| ADAMTS5 Protein | 1 | 2020 | 4 | 0.190 |
Why?
|
| Versicans | 1 | 2020 | 6 | 0.190 |
Why?
|
| Perfusion Imaging | 1 | 2021 | 50 | 0.190 |
Why?
|
| Microfilament Proteins | 3 | 2018 | 208 | 0.190 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 2 | 2021 | 12 | 0.190 |
Why?
|
| Socioeconomic Factors | 1 | 2023 | 567 | 0.190 |
Why?
|
| Gene Deletion | 3 | 2020 | 329 | 0.190 |
Why?
|
| Brain Stem | 1 | 2021 | 165 | 0.190 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2019 | 88 | 0.190 |
Why?
|
| Polymerase Chain Reaction | 6 | 2008 | 927 | 0.190 |
Why?
|
| Cohort Studies | 7 | 2021 | 2767 | 0.190 |
Why?
|
| Neovascularization, Pathologic | 3 | 2010 | 353 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 222 | 0.180 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 38 | 0.180 |
Why?
|
| Xanthine Oxidase | 4 | 2001 | 26 | 0.180 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 74 | 0.180 |
Why?
|
| Autoantigens | 1 | 2020 | 127 | 0.170 |
Why?
|
| Nuclear Proteins | 2 | 2001 | 696 | 0.170 |
Why?
|
| Autoantibodies | 1 | 2020 | 267 | 0.170 |
Why?
|
| Trans-Activators | 1 | 2001 | 429 | 0.160 |
Why?
|
| Cerebrovascular Circulation | 2 | 2021 | 212 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 7 | 2020 | 3095 | 0.160 |
Why?
|
| Stroke | 3 | 2023 | 965 | 0.160 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 1996 | 121 | 0.160 |
Why?
|
| Thrombospondin 1 | 1 | 2017 | 21 | 0.160 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 1169 | 0.160 |
Why?
|
| Gastrointestinal Tract | 1 | 2019 | 191 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2022 | 534 | 0.150 |
Why?
|
| Reactive Oxygen Species | 2 | 1999 | 480 | 0.150 |
Why?
|
| Sensitivity and Specificity | 4 | 2021 | 1991 | 0.150 |
Why?
|
| Permeability | 3 | 2021 | 137 | 0.140 |
Why?
|
| Temporal Arteries | 2 | 2009 | 9 | 0.140 |
Why?
|
| Cells, Cultured | 6 | 2017 | 2819 | 0.140 |
Why?
|
| DNA, Mitochondrial | 1 | 1996 | 183 | 0.140 |
Why?
|
| Bayes Theorem | 3 | 2022 | 361 | 0.140 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 1019 | 0.140 |
Why?
|
| Follow-Up Studies | 5 | 2023 | 3640 | 0.140 |
Why?
|
| Endothelium, Vascular | 4 | 2020 | 435 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2009 | 2271 | 0.130 |
Why?
|
| Genetic Therapy | 1 | 2017 | 342 | 0.130 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2019 | 83 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 192 | 0.130 |
Why?
|
| Cholesterol, HDL | 1 | 2016 | 165 | 0.130 |
Why?
|
| Pregnatrienes | 1 | 1995 | 14 | 0.130 |
Why?
|
| P-Selectin | 1 | 1995 | 13 | 0.130 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1995 | 71 | 0.130 |
Why?
|
| Seizures | 1 | 2017 | 297 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2019 | 381 | 0.130 |
Why?
|
| Genes, MHC Class II | 2 | 1993 | 30 | 0.130 |
Why?
|
| Keratin-1 | 1 | 2014 | 2 | 0.130 |
Why?
|
| Stress Fibers | 1 | 2014 | 23 | 0.120 |
Why?
|
| Aged | 10 | 2021 | 18415 | 0.120 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 1384 | 0.120 |
Why?
|
| Machine Learning | 3 | 2021 | 232 | 0.120 |
Why?
|
| Peyer's Patches | 1 | 1994 | 18 | 0.120 |
Why?
|
| Antigen-Antibody Complex | 1 | 2014 | 87 | 0.120 |
Why?
|
| Infant | 2 | 2014 | 3047 | 0.120 |
Why?
|
| Immunity, Innate | 1 | 2017 | 409 | 0.120 |
Why?
|
| Vitamin D | 1 | 2016 | 261 | 0.120 |
Why?
|
| Antioxidants | 1 | 1995 | 223 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 2 | 2022 | 1376 | 0.120 |
Why?
|
| Contrast Media | 4 | 2021 | 1078 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2017 | 663 | 0.110 |
Why?
|
| Chemokine CXCL2 | 3 | 2001 | 16 | 0.110 |
Why?
|
| Recombination, Genetic | 2 | 1993 | 439 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 1 | 1994 | 301 | 0.110 |
Why?
|
| Acute Disease | 3 | 2020 | 826 | 0.110 |
Why?
|
| Signal Transduction | 5 | 2019 | 3243 | 0.100 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 229 | 0.100 |
Why?
|
| Deoxyribonuclease I | 1 | 1991 | 28 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 152 | 0.100 |
Why?
|
| Inflammation | 4 | 2011 | 924 | 0.100 |
Why?
|
| Perfusion | 2 | 2021 | 203 | 0.100 |
Why?
|
| Base Sequence | 9 | 2005 | 2330 | 0.090 |
Why?
|
| Chronic Disease | 3 | 2020 | 971 | 0.090 |
Why?
|
| Enzyme Activation | 3 | 2001 | 692 | 0.090 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 2705 | 0.090 |
Why?
|
| Adrenergic alpha-Antagonists | 2 | 2001 | 35 | 0.090 |
Why?
|
| Genotype | 4 | 2021 | 1851 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2007 | 1921 | 0.090 |
Why?
|
| Transcription Factors | 4 | 2000 | 1565 | 0.090 |
Why?
|
| Phenotype | 4 | 2020 | 2380 | 0.090 |
Why?
|
| Observer Variation | 3 | 2016 | 602 | 0.090 |
Why?
|
| Interferon-gamma | 3 | 1996 | 444 | 0.080 |
Why?
|
| Ethers | 1 | 2008 | 14 | 0.080 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2008 | 49 | 0.080 |
Why?
|
| Microdissection | 1 | 2008 | 18 | 0.080 |
Why?
|
| I-kappa B Proteins | 2 | 2000 | 53 | 0.080 |
Why?
|
| Medical Illustration | 1 | 2008 | 16 | 0.080 |
Why?
|
| Magnetics | 1 | 2008 | 41 | 0.080 |
Why?
|
| Gene Targeting | 1 | 2008 | 72 | 0.080 |
Why?
|
| Point Mutation | 1 | 2009 | 246 | 0.080 |
Why?
|
| Lasers | 1 | 2008 | 106 | 0.080 |
Why?
|
| Stereotaxic Techniques | 1 | 2008 | 69 | 0.080 |
Why?
|
| Fluorocarbons | 1 | 2008 | 72 | 0.080 |
Why?
|
| Oligoclonal Bands | 1 | 2007 | 5 | 0.080 |
Why?
|
| Lipopolysaccharide Receptors | 2 | 2018 | 23 | 0.080 |
Why?
|
| Intracranial Aneurysm | 1 | 2009 | 158 | 0.080 |
Why?
|
| Myocardium | 2 | 2003 | 529 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2021 | 510 | 0.080 |
Why?
|
| Cell Movement | 3 | 1999 | 758 | 0.070 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 456 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2020 | 615 | 0.070 |
Why?
|
| Endotoxins | 2 | 1999 | 36 | 0.070 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1986 | 25 | 0.070 |
Why?
|
| Neoplasms | 1 | 2021 | 2898 | 0.070 |
Why?
|
| Interleukin-1 | 3 | 2000 | 71 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2020 | 839 | 0.070 |
Why?
|
| Molecular Sequence Data | 5 | 2005 | 3030 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 689 | 0.060 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 64 | 0.060 |
Why?
|
| Laminin | 1 | 2005 | 85 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1579 | 0.060 |
Why?
|
| Transcription Factor RelA | 2 | 2001 | 49 | 0.060 |
Why?
|
| Fibronectins | 1 | 2005 | 93 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 579 | 0.060 |
Why?
|
| Myosins | 1 | 2005 | 90 | 0.060 |
Why?
|
| DNA Repair | 2 | 1986 | 356 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1806 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 2 | 2001 | 102 | 0.060 |
Why?
|
| Chemokines | 2 | 2001 | 73 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2005 | 132 | 0.060 |
Why?
|
| Phentolamine | 2 | 2001 | 7 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 223 | 0.060 |
Why?
|
| Interleukins | 2 | 1995 | 134 | 0.060 |
Why?
|
| T-Lymphocytes | 3 | 2018 | 1195 | 0.060 |
Why?
|
| Cerebrovascular Disorders | 1 | 2004 | 143 | 0.060 |
Why?
|
| Collagen | 1 | 2005 | 269 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2001 | 1135 | 0.060 |
Why?
|
| Genomics | 1 | 2009 | 720 | 0.060 |
Why?
|
| Aging | 2 | 2020 | 691 | 0.060 |
Why?
|
| Time Factors | 3 | 2018 | 5210 | 0.060 |
Why?
|
| Peroxidase | 2 | 2000 | 51 | 0.060 |
Why?
|
| Integrin beta1 | 1 | 2022 | 33 | 0.060 |
Why?
|
| Corpus Callosum | 1 | 2003 | 56 | 0.050 |
Why?
|
| Integrins | 1 | 2022 | 76 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 1753 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2005 | 329 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2003 | 130 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2003 | 162 | 0.050 |
Why?
|
| Temporal Lobe | 1 | 2003 | 172 | 0.050 |
Why?
|
| CREB-Binding Protein | 1 | 2001 | 16 | 0.050 |
Why?
|
| Actins | 1 | 2005 | 451 | 0.050 |
Why?
|
| DNA, Complementary | 2 | 2009 | 393 | 0.050 |
Why?
|
| Gain of Function Mutation | 1 | 2021 | 13 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2001 | 68 | 0.050 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 29 | 0.050 |
Why?
|
| MutS Homolog 2 Protein | 2 | 2011 | 30 | 0.050 |
Why?
|
| Coronary Artery Bypass | 1 | 2003 | 228 | 0.050 |
Why?
|
| Tungsten | 1 | 2001 | 5 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2003 | 506 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2021 | 88 | 0.050 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2001 | 14 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 1 | 2021 | 100 | 0.050 |
Why?
|
| Animal Feed | 1 | 2001 | 20 | 0.050 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2021 | 22 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 42 | 0.050 |
Why?
|
| ADAMTS4 Protein | 1 | 2020 | 4 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2021 | 36 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2001 | 36 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2001 | 68 | 0.050 |
Why?
|
| ADAMTS1 Protein | 1 | 2020 | 6 | 0.050 |
Why?
|
| Patient Participation | 1 | 2023 | 216 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2001 | 74 | 0.050 |
Why?
|
| Hemoptysis | 1 | 2000 | 24 | 0.050 |
Why?
|
| Cell Line | 3 | 1996 | 2469 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 2020 | 148 | 0.050 |
Why?
|
| Cyclic N-Oxides | 1 | 2020 | 33 | 0.050 |
Why?
|
| Cholecalciferol | 1 | 2020 | 35 | 0.050 |
Why?
|
| Plasma | 1 | 2020 | 50 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 418 | 0.050 |
Why?
|
| Vimentin | 1 | 2020 | 44 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 101 | 0.050 |
Why?
|
| Spin Labels | 1 | 2020 | 102 | 0.050 |
Why?
|
| Proteolysis | 1 | 2020 | 100 | 0.050 |
Why?
|
| Tubulin | 1 | 2020 | 58 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 151 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2003 | 715 | 0.050 |
Why?
|
| Myosin Heavy Chains | 1 | 2020 | 88 | 0.050 |
Why?
|
| Self Report | 1 | 2021 | 288 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2021 | 182 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2001 | 152 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2021 | 278 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2019 | 68 | 0.040 |
Why?
|
| Monokines | 1 | 1999 | 3 | 0.040 |
Why?
|
| White Matter | 1 | 2020 | 80 | 0.040 |
Why?
|
| Metagenomics | 1 | 2020 | 83 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2021 | 159 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2021 | 144 | 0.040 |
Why?
|
| Protein Binding | 2 | 2016 | 1457 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 236 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 241 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2023 | 7993 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 302 | 0.040 |
Why?
|
| Patient Selection | 1 | 2023 | 686 | 0.040 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1999 | 34 | 0.040 |
Why?
|
| Prevalence | 1 | 2023 | 1239 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 294 | 0.040 |
Why?
|
| Feces | 1 | 2020 | 319 | 0.040 |
Why?
|
| Ligands | 1 | 2019 | 433 | 0.040 |
Why?
|
| Occludin | 1 | 2018 | 66 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 318 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 309 | 0.040 |
Why?
|
| Ischemia | 1 | 2000 | 243 | 0.040 |
Why?
|
| DNA Replication | 4 | 1986 | 164 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 78 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2019 | 326 | 0.040 |
Why?
|
| Models, Neurological | 1 | 2021 | 405 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 684 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 213 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 327 | 0.040 |
Why?
|
| Methylation | 2 | 1991 | 251 | 0.040 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2017 | 44 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 334 | 0.040 |
Why?
|
| Logistic Models | 1 | 2021 | 1187 | 0.040 |
Why?
|
| Gram-Negative Bacteria | 1 | 2017 | 35 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 429 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2017 | 69 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2017 | 244 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 751 | 0.040 |
Why?
|
| Intestines | 1 | 2020 | 411 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2018 | 256 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 296 | 0.040 |
Why?
|
| Hyperoxia | 1 | 1996 | 34 | 0.040 |
Why?
|
| Colitis | 1 | 2019 | 239 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 286 | 0.040 |
Why?
|
| DNA-Binding Proteins | 3 | 2000 | 1208 | 0.040 |
Why?
|
| Histological Techniques | 1 | 2016 | 35 | 0.040 |
Why?
|
| Leucine Zippers | 1 | 1996 | 10 | 0.040 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 39 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1996 | 34 | 0.040 |
Why?
|
| ADAM Proteins | 1 | 2016 | 11 | 0.040 |
Why?
|
| Cerebellum | 1 | 2018 | 247 | 0.040 |
Why?
|
| Catalase | 1 | 1996 | 48 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2017 | 369 | 0.040 |
Why?
|
| Clone Cells | 1 | 1996 | 213 | 0.040 |
Why?
|
| Iodine | 1 | 2016 | 43 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 193 | 0.040 |
Why?
|
| RNA Interference | 1 | 2017 | 369 | 0.040 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2016 | 54 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 752 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 1585 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2019 | 669 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 177 | 0.030 |
Why?
|
| Organ Size | 1 | 2016 | 364 | 0.030 |
Why?
|
| Phosphatidic Acids | 1 | 1995 | 4 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 623 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2019 | 1823 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 1996 | 177 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 190 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 879 | 0.030 |
Why?
|
| Spleen | 1 | 1996 | 430 | 0.030 |
Why?
|
| Leukocytes | 1 | 2016 | 202 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 797 | 0.030 |
Why?
|
| Laser Capture Microdissection | 1 | 2014 | 20 | 0.030 |
Why?
|
| Single-Chain Antibodies | 1 | 2014 | 17 | 0.030 |
Why?
|
| Models, Biological | 2 | 2020 | 1749 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1994 | 9 | 0.030 |
Why?
|
| Meiosis | 2 | 1993 | 80 | 0.030 |
Why?
|
| Kidney | 1 | 2000 | 1242 | 0.030 |
Why?
|
| Pseudomonas Infections | 1 | 1994 | 95 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2262 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1994 | 125 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1994 | 196 | 0.030 |
Why?
|
| Gadolinium | 1 | 2013 | 103 | 0.030 |
Why?
|
| Monocytes | 1 | 1994 | 216 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 3680 | 0.030 |
Why?
|
| Pneumonia | 1 | 1994 | 179 | 0.030 |
Why?
|
| Apoptosis | 1 | 1999 | 1683 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2014 | 458 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2010 | 1106 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 297 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1464 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 746 | 0.030 |
Why?
|
| Models, Genetic | 1 | 1996 | 926 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1991 | 157 | 0.020 |
Why?
|
| Breeding | 1 | 2010 | 39 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1993 | 267 | 0.020 |
Why?
|
| Testis | 1 | 1991 | 152 | 0.020 |
Why?
|
| Edema, Cardiac | 1 | 2010 | 3 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2015 | 398 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2010 | 68 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2010 | 29 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2013 | 548 | 0.020 |
Why?
|
| Genes | 1 | 1991 | 305 | 0.020 |
Why?
|
| Animal Structures | 1 | 2010 | 22 | 0.020 |
Why?
|
| Introns | 1 | 1991 | 289 | 0.020 |
Why?
|
| Brain Edema | 1 | 2010 | 50 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2010 | 50 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6509 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 2009 | 61 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2000 | 41 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2009 | 80 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 177 | 0.020 |
Why?
|
| Binding Sites | 1 | 1991 | 1098 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 547 | 0.020 |
Why?
|
| Immune System | 1 | 2009 | 93 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 526 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2009 | 677 | 0.020 |
Why?
|
| Cerebral Veins | 1 | 2006 | 30 | 0.020 |
Why?
|
| Hydroxyurea | 1 | 1986 | 239 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 2000 | 580 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2006 | 48 | 0.020 |
Why?
|
| DNA Polymerase I | 1 | 1986 | 9 | 0.020 |
Why?
|
| Mitosis | 1 | 1986 | 153 | 0.020 |
Why?
|
| Kinetics | 2 | 1986 | 1513 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 1221 | 0.020 |
Why?
|
| Macrophages | 1 | 2009 | 557 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2005 | 476 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 315 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 179 | 0.010 |
Why?
|
| Exons | 1 | 2005 | 450 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1986 | 597 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2003 | 148 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2000 | 1801 | 0.010 |
Why?
|
| Rats | 2 | 2000 | 3992 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 1986 | 599 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 853 | 0.010 |
Why?
|
| Alleles | 1 | 2005 | 1128 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 2062 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2002 | 253 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 560 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2000 | 1 | 0.010 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2000 | 26 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2001 | 322 | 0.010 |
Why?
|
| Neutropenia | 1 | 2000 | 215 | 0.010 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2000 | 41 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2000 | 143 | 0.010 |
Why?
|
| DNA | 1 | 1985 | 1294 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 281 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2000 | 131 | 0.010 |
Why?
|
| Receptors, Adrenergic | 1 | 1997 | 15 | 0.010 |
Why?
|
| Allopurinol | 1 | 1997 | 80 | 0.010 |
Why?
|
| Genes, Immunoglobulin | 1 | 1997 | 111 | 0.010 |
Why?
|
| Templates, Genetic | 2 | 1985 | 34 | 0.010 |
Why?
|
| Pentoxifylline | 1 | 1995 | 9 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1996 | 280 | 0.010 |
Why?
|
| Homeostasis | 1 | 1997 | 409 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1995 | 38 | 0.010 |
Why?
|
| Acyltransferases | 1 | 1995 | 41 | 0.010 |
Why?
|
| DNA, Single-Stranded | 2 | 1985 | 92 | 0.010 |
Why?
|
| Heart | 1 | 1997 | 539 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1995 | 420 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1993 | 370 | 0.010 |
Why?
|
| Plasmids | 1 | 1993 | 287 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1993 | 1041 | 0.010 |
Why?
|
| Transfection | 1 | 1993 | 896 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1993 | 729 | 0.010 |
Why?
|
| Larva | 1 | 1986 | 118 | 0.000 |
Why?
|
| Sulfuric Acid Esters | 1 | 1985 | 4 | 0.000 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 1985 | 16 | 0.000 |
Why?
|
| Alkylating Agents | 1 | 1985 | 32 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1986 | 387 | 0.000 |
Why?
|
| Adenine | 1 | 1985 | 85 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1985 | 989 | 0.000 |
Why?
|